Avidity Biosciences
RNAM
#1786
Rank
NZ$20.56 B
Marketcap
NZ$133.11
Share price
0.00%
Change (1 day)
47.81%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Last known market cap: NZ$20.56 Billion

As of November 2026 Avidity Biosciences has a market cap of NZ$20.56 Billion. This makes Avidity Biosciences the world's 1786th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026NZ$20.56 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$285.48 B 1,288.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$175.00 B 751.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$2.61 B-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$8.61 B-58.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.20 B-99.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.5 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$19.98 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$7.04 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA